Balyasny Asset Management LLC Novo Nordisk A S Transaction History

Balyasny Asset Management LLC

  • $61.9 Billion
  • Q2 2025

A detailed history of Balyasny Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Balyasny Asset Management LLC holds 4,200 shares of NVO stock, worth $209,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,200
Previous 24,900 83.13%
Holding current value
$209,076
Previous $1.73 Million 83.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$58.08 - $81.05 $71.3 Million - $99.5 Million
1,227,342 Added 399.25%
1,534,751 $106 Million
Q1 2025

May 15, 2025
SELL
$69.3 - $90.95 $29.1 Million - $38.2 Million
-420,105 Reduced 57.75%
307,409 $21.3 Million
Q4 2024

Feb 14, 2025
BUY
$85.0 - $120.04 $17.2 Million - $24.3 Million
202,223 Added 38.5%
727,514 $62.6 Million
Q3 2024

Nov 14, 2024
BUY
$119.07 - $145.42 $16.9 Million - $20.6 Million
141,647 Added 36.92%
525,291 $62.5 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $47.1 Million - $56.4 Million
383,644 New
383,644 $54.8 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $35.4 Million - $42.6 Million
403,673 New
403,673 $41.8 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $13.8 Million - $16.6 Million
104,549 New
104,549 $16.6 Million
Q3 2021

Nov 15, 2021
SELL
$84.42 - $106.62 $15.8 Million - $19.9 Million
-187,096 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$67.66 - $84.76 $12.7 Million - $15.9 Million
187,096 New
187,096 $15.7 Million
Q3 2020

Nov 16, 2020
SELL
$63.69 - $70.22 $23.1 Million - $25.5 Million
-362,808 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$58.54 - $67.94 $6.11 Million - $7.09 Million
-104,420 Reduced 22.35%
362,808 $23.8 Million
Q1 2020

May 15, 2020
SELL
$49.46 - $64.78 $11.4 Million - $14.9 Million
-229,764 Reduced 32.97%
467,228 $28.1 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $11.9 Million - $13.9 Million
-237,868 Reduced 25.44%
696,992 $40.3 Million
Q3 2019

Nov 14, 2019
BUY
$47.54 - $53.43 $31.2 Million - $35.1 Million
656,983 Added 236.43%
934,860 $48.3 Million
Q2 2019

Aug 14, 2019
BUY
$46.79 - $52.47 $6.76 Million - $7.58 Million
144,540 Added 108.4%
277,877 $14.2 Million
Q1 2019

May 15, 2019
SELL
$46.36 - $52.63 $5.95 Million - $6.75 Million
-128,263 Reduced 49.03%
133,337 $6.98 Million
Q4 2018

Feb 14, 2019
SELL
$41.54 - $47.25 $1.11 Million - $1.26 Million
-26,642 Reduced 9.24%
261,600 $12.1 Million
Q3 2018

Nov 14, 2018
SELL
$46.76 - $51.24 $4.63 Million - $5.08 Million
-99,106 Reduced 25.59%
288,242 $13.6 Million
Q2 2018

Aug 14, 2018
BUY
$44.29 - $50.42 $4.01 Million - $4.57 Million
90,568 Added 30.52%
387,348 $17.9 Million
Q1 2018

May 15, 2018
BUY
$48.49 - $58.14 $14.4 Million - $17.3 Million
296,780 New
296,780 $14.6 Million

Others Institutions Holding NVO

# of Institutions
1,735
Shares Held
319M
Call Options Held
13.7M
Put Options Held
18.9M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $112B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email